JOHN MENDLEIN Insider Trading $LIFE aTYR PHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN MENDLEIN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN MENDLEIN. JOHN MENDLEIN is Director in ACLARA BIOSCIENCES INC ($ACLA) and CEO & Executive Chariman in aTYR PHARMA INC ($LIFE) and CEO and Director in aTYR PHARMA INC ($LIFE) and CEO and Executive Chairman in aTYR PHARMA INC ($LIFE) and Director in aTYR PHARMA INC ($LIFE) and See Remarks in aTYR PHARMA INC ($LIFE) and Director in FATE THERAPEUTICS INC ($FATE) and Director in Editas Medicine, Inc. ($EDIT).

JOHN MENDLEIN in aTYR PHARMA INC

Trading Symbol: LIFE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN MENDLEIN: CEO and Director, See Remarks, CEO and Executive Chairman, CEO & Executive Chariman
Holdings: 420,382 shares
Current Value: $1,429,299
Latest Transaction: May 10 2019
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JOHN MENDLEIN in aTYR PHARMA INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACLA, LIFE, EDIT, FATE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 10 2019LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorOption ExerciseA0.5820,00011,66820,000
Dec 26 2018LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorBuyP0.42195,00082,602615,382420.4 K to 615.4 K (+46.39 %)
Dec 26 2018LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorBuyP0.4150,00020,645420,382370.4 K to 420.4 K (+13.50 %)
May 17 2018LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorOption ExerciseA1.3520,00027,00020,000
Jan 02 2018LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorOption ExerciseA3.8032,000121,60032,000
Sep 05 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorOption ExerciseP4.6414,15165,66114,151
Sep 05 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP2.6537,736100,000367,883330.1 K to 367.9 K (+11.43 %)
Apr 26 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP3.00124372327,647327.5 K to 327.6 K (+0.04 %)
Apr 20 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP3.001,5524,656327,523326 K to 327.5 K (+0.48 %)
Apr 20 2017LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP3.001,0003,000325,971325 K to 326 K (+0.31 %)
Dec 21 2016LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP2.2069,000151,662324,971256 K to 325 K (+26.96 %)
Apr 07 2016LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP3.522,5008,800250,971248.5 K to 251 K (+1.01 %)
Apr 06 2016LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorBuyP3.552,5008,875248,471246 K to 248.5 K (+1.02 %)
Jan 29 2016LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorOption ExerciseA6.14135,000828,900135,000
Jan 06 2016LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorOption ExerciseA9.13148,7321,357,923148,732
Oct 05 2015LIFEaTYR PHARMA INCMENDLEIN JOHNSee RemarksOption ExerciseA10.2465,070666,31765,070
Oct 05 2015LIFEaTYR PHARMA INCMENDLEIN JOHNSee RemarksOption ExerciseA10.2471,000727,04071,000
May 14 2015LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and Executive C ...Option ExerciseC0.0021,12200
May 14 2015LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and Executive C ...Option ExerciseC0.00170,21800
May 14 2015LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and Executive C ...BuyC0.0024,0550245,971221.9 K to 246 K (+10.84 %)
May 08 2015LIFEaTYR PHARMA INCMENDLEIN JOHNCEO & Executive Cha ...Option ExerciseA14.00163,4372,288,118163,437

Page:   1

Contact us | Follow us on Twitter